Therefore, the establishment of sensitive immunoassays to determine total and polyQ-expanded ATXN2 in human biofluids is not only of interest for the rare disease SCA2 but also for other (rare) neurological disorders. The gene discussed is ATXN2; the disease is spinocerebellar ataxia type 2.